Chest CT-scan
ProcedurePatients with a suspicion of acquired pneumonia visiting the emergency department will do a chest CT-scan
NCT Number: NCT01574066
Primary objective : to estimate impact of CT-scan on diagnostic for emergency department (ED) patients with suspected Community-acquired Pneumonia (CAP).
Secondary objective: to estimate impact of CT-scan on treatment (antimicrobial therapy) and site of care for ED patients with suspected CAP.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Bichat Hospital, Paris, France
Rational: Community-acquired pneumonia (CAP) is a frequent infectious disorder in patients visiting the ED. CAP is responsible for high morbidity and associated-mortality is increasing in Western countries. CAP corresponds to invasion of the lung by pathogens. Diagnosis depends on clinical and X-ray assessment. However, these signs and symptoms are poorly specific and are often lacking. As prognosis depends on precocious and fitted antimicrobial treatment, making CAP diagnosis in a short time span (4-8 hours) is mandatory. Preliminary studies suggest that chest CT-scan could over-performed X-ray for diagnosis of CAP. Consensus conferences suggest the use of CT-scan in patients with uncertain diagnosis and unusual presentation and outcome. Because CT-scan is currently easily available, its use in a first intent is questionable for ED patients with suspected CAP.
Primary objective: to estimate impact of CT-scan on diagnostic for ED patients with suspected CAP.
Secondary objective: to estimate impact of CT-scan on treatment (antimicrobial therapy) and site of care for ED patients with suspected CAP.
Prospective multicenter study to measure chest CT-scan impact. 350 patients visiting the ED of 4 inner tertiary teaching hospitals in Paris, France, with suspected CAP.
Management: Patients will be managed according to current guidelines, including conventional chest X-ray.
Evaluation criteria. Attending ED physicians will implement pre- and post-test proforma for diagnosis (CAP) level of certainty, treatment (antimicrobial agents), site of care, before and after chest CT-scan. Comparison of ED physician's answers before/after CT-scan. Patients will be followed until day 28. An adjudication committee (1 pneumologist, 1 infectiologist, 1 radiologist)will review patients' data for gold standard diagnosis.
Statistical considerations: The investigators hypothesize that chest CT-scan wil modify diagnosis certainty in 20%. This implies that 300 participants should be enrolled to allow assessment of changes in 15 % et 25 %. Undue changes will be calculated a posteriori when diagnosis gold standard will be established by adjudication committee.
Anticipated results: Chest CT-scan should improve diagnosis certainty, treatment and site-of-care in patients visiting the ED with suspected CAP. If this is observed in at least 20%, the investigators will measure impact of chest CT-scan in a prospective randomized interventional study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients with a suspicion of acquired pneumonia visiting the emergency department will do a chest CT-scan
Time frame: in 28 days
Percentage of diagnoses modified by chest CT-scan.
Time frame: in 28 days
Percentage of treatments changes (antimicrobial therapy) modified by chest CT-scan
Time frame: in 28 days
Percentage of site-of-care (admission/non admission) modified by chest CT-scan
Time frame: at day of inclusion (day 1)
Identification of viral and bacterial agents from nasal and pharyngeal swabs
Time frame: at day of inclusion (day 1)
Determination of markers of infection in the blood
Time frame: at day of inclusion (day 1)
Determination of markers of infection and of inflammation in urine
Assistance Publique - Hôpitaux de Paris
Other
Chest CT-scan for the Diagnosis of Community-acquired Pneumonia in Patients Visiting the Emergency Department
Acronym: PACSCAN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03672994
Asthma, Breathlessness
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT05568654
Antimicrobial Stewardship, Community-Acquired Infections
Vero Beach, Florida, United States
View Trial DetailsNCT05452226
COPD Exacerbation Acute, Community-Acquired Infections
Burlington, Vermont, United States
View Trial DetailsNCT05962606
Community-Acquired Infections, Community-Acquired Pneumonia
Birmingham, Alabama, United States
View Trial Details